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Human milk samples t h a t i n h i b i t bilirubin-UDP-glucuronyl t r a n sf e r a s e (UDPGT) a c t i v i t y i n v i t r o a r e a s s o c i a t e d with t h e syndrome of b r e a s t milk jaundice. W e have reported t h a t t h e i n h i b i t o r ap-
pears t o be non-esterified f a t t y a c i d and t h e milk samples assoc i a t e d with the c l i n i c a l syndrome e x h i b i t s i g n i f i c a n t l y higher unstimulated l i p a s e a c t i v i t y (P<O.Ol) and s p e c i f i c a c t i v i t y (P< 0.001) than c o n t r o l s using a pH-stat assay with t r i b u t y r i n as s u b s t r a t e .
(Pediatr. Xes. g : 1 3 2 8 , 1981). The p r e s e n t study was done t o t e s t whether t h a t l i p o l y t i c act i v i t y was due t o a s p e c i f i c l i p a s e o r t o a non-specific e s t e rase. Two water s o l u b l e s u b s t r a t e s were t e s t e d : p-nitrophenyl (p-NP) a c e t a t e ( f o r non-specific e s t e r a s e ) and p-NP butyrate ( a f a t t y acyl e s t e r ) . Assays with t h e s e s u b s t r a t e s were performed simultaneously along w i t h t h e above t r i b u t r i n assay using 23 human milk samples a s sources o f enzyme. Enzyme u n i t s a r e defined a s 1 uM of s u b s t r a t e r e l e a s e d by 1 m l of milk p e r minute. Lipase a c t i v i t y ( t r i b u t r i n assay) ranged from 3.1 t o 11.1 u n i t s . Activ i t y vs. p-NP b u t y r a t e ( f a t t y a c y l e s t e r ) ranged from 1.1 t o 23.7 u n i t s and a c t i v i t y vs. p-NP a c e t a t e (non-specific e s t e r ) ranged from 0.3 t o 2.6 u n i t s . T r i b u t y r i n assay a c t i v i t y correlat e d p o s i t i v e l y with p-NP b u t y r a t e a c t i v i t y (-0.66, P<0.001) b u t d i d n o t c o r r e l a t e withp-NP a c e t a t e a c t i v i t y (~0 . 0 7 , N.S.) . These r e s u l t s a r e c o n s i s t e n t with t h e hypothesis t h a t t h e unstimulated enzyme a c t i v i t y we described a s s o c i a t e d w i t h b r e a s t milk jaundice i s produced by a l i p a s e and not a non-specific e s t e r a s e . It is g e n e r a l l y expected t h a t t h e second-born twin may have an a c u t e d i s t r e s s due t o t h e adverse e f f e c t s of intraparturn per i o d and t h e small twin i s u s u a l l y a s u b j e c t f o r i n t r a u t e r i n e chronic d i s t r e s s which may both l e a d t o an i n t r a c r a n i a l bleed.
PERIVENTRICULAR (PVH)
,
W e s t u d i e d 21 p a i r s of low b i r t h weight (LBW) twin pregnancies t o s e e whether t h e incidence and s e v e r i t y of US abnormalities, such a s PVH, IVH, PH and VD, a r e d i f f e r e n t between t h e p a i r s .
The study population had a g e s t a t i o n a l age of (a) 32.8 wk, b i r t h wt o f 1649 g , 5 minute Apgar score of 7.9 and t h e p o s t n a t a l age a t f i r s t US examination of 45. 2 11 4 1 9 4 0 The e n t i r e comparison a l s o shows no s i g n i f i c a n t d i f f e r e n c e between t h e sequence and s i z e based groups a s they r e l a t e t o cran i a l US and o t h e r r e l e v a n t c l i n i c a l parameters.
There appears t o be no evidence of r e l a t i v e i n c r e a s e i n t h e incidence o r sev e r i t y of PVH,IVH,PH and V D i n twin i n f a n t s during i m e d i a t e , e a r l y and l a t e neonatal period.
MATURATION OF RESPIRATORY PATTWNS IN VERY U)W BIRTH WEIGHT (VLBW) INFANTS:
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TIN PROTOPORPHYRIN (TP) AND THE EXCRETION RATE OF + 1 AQA CO (VeCO) I N ANTIBIOTIC-TREATED NEONATAL RATS WITH
I A'Cu" ARTIFICIAL HEMATOMAS. Andrew P o s s e l t , Linda Kwong, B a r r e t t Cowan, Henk Vreman, David K. Stevenson. Stanford Univ. Sch. of Med., Dept. of P l l i a t r i c s , Stanford, CA.
Previous s t u d i e s showed t h a t TP i n h i b i t s t i s s u e heme oxygenase a c t i v i t y (HO) and lowers serum t o t a l b i l i r u b i n l e v e l s [B],
but does not e f f e c t the VeCO of neonatal r a t s with and without a r t i f i c i a l l y created hematomas (H). It i s possible t h a t i n t e s t i n a l b a c t e r i a play a r o l e i n t h i s model by metabolizing excreted heme t o CO. Rat l i t t e r s , with i n t e s t i n e s s t e r i l i z e d by a n t i b i o t i c s , were divided i n t o 3 groups of 3 r a t s each. At 12 h postpartum (t=O), the TP/H r a t s were i n j e c t e d with TP (65 ~m o l e s / k g ) . Hematomas were given t o H and TP/H r a t s (t=45 h ) . Rats were s a c r i f i c e d a t t=113 h. The [ B l of t h e TP/H r a t s was not reduced, but h e p a t i c H O a c t i v i t y was suppressed ( p < .005) when compared t o t h e H c o n t r o l group. The o v e r a l l average VeCO of H r a t s was increased by % 45% over S r a t s and TP was effect i v e i n , d e l a y i n g and suppressing t h i s increase; t h e i n h i b i t i o n of average VeCO was n , 25%. The r e s u l t s suggest t h a t i n a n t ib i o t i c -t r e a t e d r a t s with a r t i f i c i a l hematomas: 1) s i n g l e dose TP was e f f e c t i v e i n lowering VeCO and thus t o t a l b i l i r u b i n format i o n and 2) i n t e s t i n a l b a c t e r i a may c o n t r i b u t e s i g n i f i c a n t l y t o VeCO, i f endogenous heme degradation i s i n h i b i t e d .
PROLONGED HYPERCALCEMIA I N A NEONATE FOLLOWING

RHABDOMYOLYSIS AND ACUTE RENAL FAILURE (ARF)
. During t h e 10 day o l i g u r i c period, 587 mg/kg of intravenous Ca gluconate was used t o maintain normocalcemia, and p e r i t o n e a l d i a l y s i s was required. Two weeks a f t e r d i u r e s i s began, hypercalcemia developed. Serum Ca p e r s i s t e d between 13 and 16 mg/dl f o r 6 weeks. Postulated mechansims f o r hypercalcemia following rhabdomyolysis and ARF include 1 ) elevated serum c a l c i d i o l , 2) inappropriate r e l e a s e of PTH, and 3) resorption of muscle c a l c i f i c a t i o n s . I n t h i s case serum PTH was low normal d e s p i t e t h e marked hypercalcemia. C a l c i t r i o l l e v e l was 131 pg/ml and c a l c i d i o l l e v e l was 27 ng/ml (both WNL).
Late hypercalcemia can occur i n s t r e s s e d neonates with s i g n s of myoglobinura associated ARF. The hypotheses of inappropriate PTH r e l e a s e and r e s o r p t i o n of muscle c a l c i f i c a t i o n s a r e supported by t h i s case. To assess the efficacy of prophylactic I therapy in decreasing the incidence of PDA, premature infants < 1400 n birthweinht with resoiratory distress ( 0 or ventilator (IMV) requirement a t -> 6 hrs. ofkage) were randomize3 to receive intravenous I or placebo (P). Infants were pair-matched for birthweight, gestational age and severity of respiratory distress at the time of randomization: one of each pair received I, the other P. I (0.2 mglkg) was given intravenously a t < 24 hrs. of age and every 12 hrs. thereafter for 3 doses total. After initial 3 doses, I
was prescribed in any infant who developed a hemodynamically significant PDA. Courses of study infants have been analyzed for PDA and severity of respiratory disease (time on IMV and on 0 Results: Prophylactic I decreases incidence of PDA but has no effect on respiratory disease. The trend toward increased incidence and severity of IVH is not statistically significant. Ongoing study monitored by sequential analysis will determine if trend toward increased incidence and/or severity of IVH is real.
